Otoband
Otoband is a medical device with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
66.7%
2 of 3 finished
33.3%
1 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluation of the OtoBand in Subjects With Self-reported Vertigo to Reduce Severity of Vertigo in a Real-world Setting
Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness
Efficacy of a Non-invasive Vestibular System Masking for Improving Outcomes Following Acute Unilateral Vestibulopathy
Evaluation of the OtoBand as a Treatment to Reduce the Perceived Loudness of Tinnitus
Efficacy of a Transcranial Vibrating System for Mitigation of Migraine Associated Vertigo
Clinical Trials (6)
Evaluation of the OtoBand in Subjects With Self-reported Vertigo to Reduce Severity of Vertigo in a Real-world Setting
Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness
Efficacy of a Non-invasive Vestibular System Masking for Improving Outcomes Following Acute Unilateral Vestibulopathy
Evaluation of the OtoBand as a Treatment to Reduce the Perceived Loudness of Tinnitus
Efficacy of a Transcranial Vibrating System for Mitigation of Migraine Associated Vertigo
Prevention of Unmitigated Chemotherapy-induced Emesis
All 6 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 6